Tower Research Capital (TRC)’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,657
| Closed | -$88K | – | 6041 |
|
|
2020
Q4 | $88K | Sell |
7,657
-12,834
| -63% | -$146K | ﹤0.01% | 2483 |
|
|
2020
Q3 | $141K | Buy |
20,491
+13,912
| +211% | +$91.3K | ﹤0.01% | 2873 |
|
|
2020
Q2 | $43K | Buy |
+6,579
| New | +$42.5K | ﹤0.01% | 3172 |
|
|
2019
Q4 | – | Sell |
-8,705
| Closed | -$55K | – | 4773 |
|
|
2019
Q3 | $55K | Buy |
8,705
+6,759
| +347% | +$50.4K | ﹤0.01% | 1736 |
|
|
2019
Q2 | $14K | Sell |
1,946
-2,894
| -60% | -$19.1K | ﹤0.01% | 2392 |
|
|
2019
Q1 | $30K | Buy |
4,840
+644
| +15% | +$7.46K | ﹤0.01% | 2056 |
|
|
2018
Q4 | $48K | Buy |
+4,196
| New | +$71.6K | ﹤0.01% | 1319 |
|
|
2018
Q3 | – | Sell |
-1,025
| Closed | -$16K | – | 4469 |
|
|
2018
Q2 | $16K | Buy |
1,025
+579
| +130% | +$9.1K | ﹤0.01% | 2569 |
|
|
2018
Q1 | $8K | Buy |
446
+37
| +9% | +$730 | ﹤0.01% | 2572 |
|
|
2017
Q4 | $7K | Sell |
409
-291
| -42% | -$4.02K | ﹤0.01% | 2776 |
|
|
2017
Q3 | $10K | Buy |
+700
| New | +$11K | ﹤0.01% | 3093 |
|
|
2017
Q2 | – | Sell |
-432
| Closed | -$7K | – | 3752 |
|
|
2017
Q1 | $7K | Sell |
432
-72
| -14% | -$1.44K | ﹤0.01% | 2049 |
|
|
2016
Q4 | $11K | Sell |
504
-366
| -42% | -$7.51K | ﹤0.01% | 2607 |
|
|
2016
Q3 | $16K | Buy |
870
+822
| +1,713% | +$18.5K | ﹤0.01% | 1759 |
|
|
2016
Q2 | $1K | Buy |
+48
| New | +$1.34K | ﹤0.01% | 4271 |
|
Tower Research Capital (TRC)'s ARA Position: Q1 2021 in Review
Tower Research Capital (TRC) sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 7,657 shares — an estimated $88K sold.
Tower Research Capital (TRC) first reported a position in ARA in Q2 2016 and held it in 15 quarters. The position peaked at $141K in Q3 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Tower Research Capital (TRC) reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 7,657 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $88K.
- Tower Research Capital (TRC) first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 15 quarters.
- Tower Research Capital (TRC)'s American Renal Associates Holdings, Inc position peaked at $141K in Q3 2020.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.